Skip to content

An Prospective analysis of clinical effectiveness for 3D printed, customized surgical skin cancer resection guide

An Prospective analysis of clinical effectiveness for 3D printed, customized surgical skin cancer resection guide

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CRIS
Registry ID
KCT0004705
Enrollment
160
Registered
2020-02-05
Start date
2020-02-10
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Control group: The skin cancer resection proceeds according to the conventional method. Preoperatively, the patients underwent 2D and 3D imaging evaluation for the cancer lesion. Intr

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: a) men and women patients from 20 to 90 years of age b) Patients who are clinically confirmed to have skin cancer, the type of skin cancer is to include only lesions that fall under the following items. i. Actinic keratosis ii. Bowen’s disease iii. Squamous cell carcinoma iv. Basal cell carcinoma v. Sebaceous carcinoma vi. Trichilemmal carcinoma vii. Sweat gland carcinoma viii. Extramammary Paget’s disease ix. Merkel cell carcinoma x. Dermatofibrosarcoma protuberans (DFSP) xi. angiosarcoma c) a patient who is planning extensive resection due to skin cancer. d) Person whose subject fully understands and agrees in writing to consent documents

Exclusion criteria

Exclusion criteria: a) Patients who have contraindications of CT, MRI i. Those with an inserted electrical device, clip for the prevention of aneurysm, artificial of metallic material around the eyeball ii. Patients who have Claustrophobia iii. Contrast medium allergy patient iv. Patients with kidney failure (Standard: Creatine >2.0) v. Pregnant patient b) Patients deemed unsuitable to participate in this clinical trial at the Investigator's discretion

Design outcomes

Primary

MeasureTime frame
tumor existence of surgical margin

Secondary

MeasureTime frame
Distance from tumor lesion and surgical excision margin;Operation time;Surgeon's Satisfaction

Countries

Korea, Republic of

Contacts

Public ContactMin Kim

Asan Medical Center

minjikim1031@naver.com+82-2-3010-3323

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026